Literature DB >> 9676760

The effects of ethnicity on disease patterns in 472 Orientals with systemic lupus erythematosus.

J Thumboo1, K Y Fong, H H Chng, E T Koh, H P Chia, K H Leong, W H Koh, H S Howe, K P Leong, M H Wong, S M Chew, P Chai, L H Goh, T J Goon, T C Lau, W S Lim, W Y Pek, K L Tong, W L Yang, P H Feng, M L Boey.   

Abstract

OBJECTIVE: To determine the effects of ethnicity on disease manifestations in Oriental patients with systemic lupus erythematosus (SLE) and to describe the risk of developing renal or central nervous system (CNS) involvement with time.
METHODS: A retrospective study of 472 patients with SLE seen at the only Rheumatology Unit in Singapore. The effect of ethnicity on selected disease manifestations at diagnosis was assessed after adjusting for demographic variables using multiple logistic regression. The probability of developing selected disease manifestations with time was determined using the Kaplan-Meier product limit method.
RESULTS: At diagnosis, Malays had a higher risk of renal or CNS involvement than Chinese (OR 2.26, 95% CI 1.21 to 4.21, and OR 3.07, 95% CI 1.01 to 9.34, respectively), and Indians a lower risk of malar rash and a higher risk of oral ulcers than Chinese (OR 0.30, 95% CI 0.13 to 0.68, and OR 2.90, 95% CI 1.45 to 7.34, respectively). The prevalence of renal or CNS involvement in the entire cohort increased with time, reaching 75.6% (95% CI 66.1% to 85.0%) and 16.7% (95% CI 11.7% to 21.6%), respectively, after 18 years of disease.
CONCLUSION: Ethnicity influenced disease manifestations at diagnosis in this cohort of Oriental patients with SLE. Renal or CNS involvement developed in previously unaffected patients up to 18 years after diagnosis, highlighting the need for continued vigilance in patients with lupus.

Entities:  

Mesh:

Year:  1998        PMID: 9676760

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  The Sarawak lupus cohort: clinical features and disease patterns of 633 SLE patients in a single tertiary centre from East Malaysia.

Authors:  C L Teh; G R Ling; Wan Sharifah Aishah
Journal:  Rheumatol Int       Date:  2014-06-07       Impact factor: 2.631

2.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).

Authors:  Graciela S Alarcón; Gerald McGwin; Ana M Bertoli; Barri J Fessler; Jaime Calvo-Alén; Holly M Bastian; Luis M Vilá; John D Reveille
Journal:  Ann Rheum Dis       Date:  2007-03-27       Impact factor: 19.103

3.  Clinical and laboratory manifestations of yemeni patients with systemic lupus erythematosus.

Authors:  Hassan A Al-Shamahy; Najla H M Dhaifallah; Yahya M Al-Ezzy
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

4.  Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.

Authors:  Surjit Singh; Mukesh Kumar Gupta; Jasmina Ahluwalia; Paramjeet Singh; Prahbhjot Malhi
Journal:  Rheumatol Int       Date:  2009-03-22       Impact factor: 2.631

5.  Systemic lupus erythematosus in Egyptian children.

Authors:  Samia Salah; Hala Mohamed Lotfy; Samar M Sabry; Azza El Hamshary; Heba Taher
Journal:  Rheumatol Int       Date:  2009-03-20       Impact factor: 2.631

6.  Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases.

Authors:  Seung-Woo Baek; Myung-Won Lee; Hae-Won Ryu; Kyu-Seop Lee; Ik-Chan Song; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Korean J Hematol       Date:  2011-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.